Updated Analysis From KEYNOTE-189: Pembrolizumab or Placebo Plus Pemetrexed and Platinum for Previously Untreated Metastatic Nonsquamous Non-Small-Cell Lung Cancer

Gadgeel, S; Rodriguez-Abreu, D; Speranza, G; Esteban, E; Felip, E; Domine, M; Hui, RN; Hochmair, MJ; Clingan, P; Powell, SF; Cheng, SYS; Bischoff, HG; Peled, N; Grossi, F; Jennens, RR; Reck, M; Garon, EB; Novello, S; Rubio-Viqueira, B; Boyer, M; Kurata, T; Gray, JE; Yang, J; Bas, T; Pietanza, MC; Garassino, MC

Gadgeel, S (corresponding author), Univ Michigan, Dept Internal Med, Div Hematol Oncol, 1500 E Med Ctr Dr,7217CC, Ann Arbor, MI 48109 USA.

JOURNAL OF CLINICAL ONCOLOGY, 2020; 38 (14): 1505

Abstract

PURPOSE In KEYNOTE-189, first-line pembrolizumab plus pemetrexed-platinum significantly improved overall survival (OS) and progression-free survival (......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索